2.01
0.05 (2.55%)
| Penutupan Terdahulu | 1.96 |
| Buka | 1.98 |
| Jumlah Dagangan | 1,585,746 |
| Purata Dagangan (3B) | 3,080,806 |
| Modal Pasaran | 688,574,720 |
| Harga / Pendapatan (P/E TTM) | 22.33 |
| Harga / Pendapatan (P/E Ke hadapan) | 5.44 |
| Harga / Jualan (P/S) | 0.910 |
| Harga / Buku (P/B) | 1.13 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 May 2026 |
| Margin Keuntungan | 3.57% |
| Margin Operasi (TTM) | 13.69% |
| EPS Cair (TTM) | 0.070 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 2.60% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -88.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 82.71% |
| Nisbah Semasa (MRQ) | 5.22 |
| Aliran Tunai Operasi (OCF TTM) | 150.72 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 74.77 M |
| Pulangan Atas Aset (ROA TTM) | 4.26% |
| Pulangan Atas Ekuiti (ROE TTM) | 4.43% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (US) | Menurun | Menurun |
| Health Information Services (Global) | Menurun | Menurun | |
| Stok | GoodRx Holdings, Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.63 |
|
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 12.51% |
| % Dimiliki oleh Institusi | 62.88% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Francisco Partners Management, Lp | 31 Dec 2025 | 60,078,184 |
| Silver Lake Group, L.L.C. | 31 Dec 2025 | 3,532,276 |
| Petrus Trust Company, Lta | 31 Dec 2025 | 3,098,559 |
| Technology Crossover Management X, Ltd. | 31 Dec 2025 | 1,653,566 |
| Connor, Clark & Lunn Investment Management Ltd. | 31 Dec 2025 | 1,397,551 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 3.50 (Wells Fargo, 74.13%) | Beli |
| 3.50 (Citigroup, 74.13%) | Beli | |
| Median | 3.00 (49.25%) | |
| Rendah | 2.50 (Goldman Sachs, 24.38%) | Pegang |
| Purata | 3.05 (51.74%) | |
| Jumlah | 2 Beli, 3 Pegang | |
| Harga Purata @ Panggilan | 2.17 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Wells Fargo | 04 Mar 2026 | 3.50 (74.13%) | Beli | 2.18 |
| Citigroup | 03 Mar 2026 | 3.50 (74.13%) | Beli | 2.07 |
| 09 Jan 2026 | 4.50 (123.88%) | Beli | 2.80 | |
| Goldman Sachs | 02 Mar 2026 | 2.50 (24.38%) | Pegang | 2.17 |
| Mizuho | 27 Feb 2026 | 3.00 (49.25%) | Pegang | 1.87 |
| Jefferies | 22 Jan 2026 | 2.75 (36.82%) | Pegang | 2.57 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 05 Feb 2026 | Pengumuman | GoodRx Powers Pricing for Leading Brand Medications on TrumpRx |
| 02 Feb 2026 | Pengumuman | GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale |
| 02 Feb 2026 | Pengumuman | 60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership |
| 28 Jan 2026 | Pengumuman | GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call |
| 13 Jan 2026 | Pengumuman | Surescripts and GoodRx Partner to Advance Patient Price Transparency |
| 08 Jan 2026 | Pengumuman | GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies |
| 05 Jan 2026 | Pengumuman | GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |